Alkermes (ALKS) Operating Margin (2010 - 2026)
Alkermes' (ALKS) quarterly Operating Margin came in at 12.29% in Q1 2026, down 1679.0% year-on-year from 0.78% in Q1 2025, and down 181.32% on a QoQ basis from 15.11% in Q4 2025.
Alkermes (ALKS) Operating Margin (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Operating Margin data on file, last reported at 12.29% in Q1 2026.
- On a quarterly basis, Operating Margin fell 1679.0% year-over-year to 12.29% in Q1 2026; TTM through Mar 2026 was 12.28%, a 1356.0% decrease from a year earlier, with the FY2025 full-year figure at 17.21%, down 980.0% from the prior year.
- Operating Margin for Q1 2026 stood at 12.29%, down from 15.11% in the prior quarter.
- Over the last five years, Operating Margin for ALKS reached as high as 45.56% in Q2 2023 and fell as low as 1895.03% in Q3 2022.
- Historically, Operating Margin has averaged 159.1% across 5 years, with a median of 15.11% in 2025.
- Across the five-year window, Operating Margin plunged 188835 bps in 2022 and surged 191845 bps in 2023, its largest moves.
- Year by year, Operating Margin stood at 37.94% in 2022, then tumbled by 62 bps to 14.47% in 2023, then soared by 161 bps to 37.84% in 2024, then tumbled by 60 bps to 15.11% in 2025, then tumbled by 181 bps to 12.29% in 2026.
- Per Business Quant data, the three most recent Operating Margin figures were 12.29% in Q1 2026, 15.11% in Q4 2025, and 22.6% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | -12.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.29% |
| Dec 31, 2025 | 15.11% |
| Sep 30, 2025 | 22.60% |
| Jun 30, 2025 | 23.80% |
| Mar 31, 2025 | 4.50% |
| Dec 31, 2024 | 37.84% |
| Sep 30, 2024 | 27.70% |
| Jun 30, 2024 | 27.53% |
| Mar 31, 2024 | 12.36% |
| Dec 31, 2023 | 14.47% |
| Sep 30, 2023 | 23.41% |
| Jun 30, 2023 | 45.56% |
| Mar 31, 2023 | -3.82% |
| Dec 31, 2022 | 37.94% |
| Sep 30, 2022 | -1,895.03% |
| Jun 30, 2022 | -1,076.78% |
| Mar 31, 2022 | -9.54% |
| Dec 31, 2021 | 39.89% |
| Sep 30, 2021 | -6.68% |
| Jun 30, 2021 | 1.46% |